Autonomix Medical (AMIX) Research & Development (2022 - 2025)

Autonomix Medical (AMIX) has 4 years of Research & Development data on file, last reported at $1.7 million in Q4 2025.

• On a quarterly basis, Research & Development rose 65.13% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $7.2 million, a 87.0% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, up 112.36% from the prior year.
• Research & Development for Q4 2025 stood at $1.7 million, down from $2.4 million in the prior quarter.
• Over the last five years, Research & Development for AMIX reached as high as $2.4 million in Q3 2025 and fell as low as $199000.0 in Q4 2022.
• Historically, Research & Development has averaged $1.0 million across 4 years, with a median of $954000.0 in 2024.
• Across the five-year window, Research & Development soared 245.23% in 2023 and surged 51.97% in 2024, its largest moves.
• Year by year, Research & Development stood at $199000.0 in 2022, then surged by 245.23% to $687000.0 in 2023, then jumped by 51.97% to $1.0 million in 2024, then soared by 65.13% to $1.7 million in 2025.
• Per Business Quant data, the three most recent Research & Development figures were $1.7 million in Q4 2025, $2.4 million in Q3 2025, and $1.6 million in Q2 2025.